Population pharmacokinetic analysis of oral lansoprazole suspension in pediatric patients.

被引：0
|
作者：
Palaparthy, R
DiGiacinto, J
Kastrissios, H
Scheibel, W
Graumlich, JF
机构：
[1] Univ Illinois, Coll Pharm, Chicago, IL USA
[2] Univ Illinois, Coll Med, Peoria, IL 61656 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2001年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P57 / P57
页数：1
相关论文
共 50 条
  • [1] Population pharmacokinetic analysis of atomoxetine in pediatric patients.
    Witcher, J
    Kurtz, D
    Heathman, M
    Sauer, J
    Smith, B
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P46 - P46
  • [2] Population pharmacokinetic analysis of gefitinib in pediatric cancer patients.
    Motl, SE
    Freeman, BB
    Muralidharan, BK
    Panetta, JC
    Daw, NC
    Geyer, R
    Furman, WL
    Stewart, CF
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9071S - 9071S
  • [3] Population Pharmacokinetic Analysis of Oral Baclofen in Pediatric Patients with Cerebral Palsy
    He, Y.
    Brunstrom-Hernandez, J. E.
    Thio, L. L.
    Lackey, S.
    Gaebler-Spira, D.
    Kuroda, M. M.
    Stashinko, E.
    Hoon, A. H.
    Vargus-Adams, J.
    Stevenson, R. D.
    Lowenhaupt, S.
    McLaughlin, J. F.
    Christensen, A.
    Dosa, N. P.
    Butler, M.
    Schwabe, A.
    Lopez, C.
    Roge, D.
    Kennedy, D.
    Tilton, A. H.
    Krach, L. E.
    Lewandowski, A.
    Jusko, W. J.
    [J]. ANNALS OF NEUROLOGY, 2013, 74 : S185 - S185
  • [4] Lansoprazole suspension pharmacokinetics-pharmacodynamics (PK-PD) in critically ill pediatric patients.
    DiGiacinto, J
    Graumlich, JF
    Bysani, GK
    Torres, A
    Shushunov, S
    Kastrissios, H
    Scheibel, LW
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 104 - 104
  • [5] A population pharmacokinetic model for posaconazole intravenous solution and oral powder for suspension formulations in pediatric patients with neutropenia
    Winchell, Gregory
    de Greef, Rik
    Ouerdani, Aziz
    Fauchet, Floris
    Wrishko, Rebecca E.
    Mangin, Eric
    Bruno, Christopher
    Waskin, Hetty
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (04)
  • [6] A Population Pharmacokinetic Modeling and Simulation Study of Posaconazole Oral Suspension in Immunocompromised Pediatric Patients: A Short Communication
    Elkayal, Omar
    Spriet, Isabel
    Uyttebroeck, Anne
    Colita, Anca
    Annaert, Pieter
    Allegaert, Karel
    Smits, Anne
    Van Daele, Ruth
    Dreesen, Erwin
    [J]. THERAPEUTIC DRUG MONITORING, 2021, 43 (04) : 512 - 518
  • [7] A pharmacokinetic study of tinzaparin in pediatric patients.
    Kuhle, S
    Massicotte, P
    Andrew, M
    Dinyari, M
    Marzinotto, V
    Mitchell, D
    Pieniaszek, H
    Vegh, P
    Mitchell, L
    [J]. BLOOD, 2002, 100 (11) : 123B - 123B
  • [8] Escitalopram and Sertraline Population Pharmacokinetic Analysis in Pediatric Patients
    Poweleit, Ethan A.
    Taylor, Zachary L.
    Mizuno, Tomoyuki
    Vaughn, Samuel E.
    Desta, Zeruesenay
    Strawn, Jeffrey R.
    Ramsey, Laura B.
    [J]. CLINICAL PHARMACOKINETICS, 2023, 62 (11) : 1621 - 1637
  • [9] Population pharmacokinetic analysis of topotecan in pediatric cancer patients
    Schaiquevich, Paula
    Panetta, John C.
    Iacono, Lisa C.
    Freeman, Burgess B., III
    Santana, Victor M.
    Gajjar, Amar
    Stewart, Clinton F.
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (22) : 6703 - 6711
  • [10] BIOAVAILABILITY AND POPULATION PHARMACOKINETIC ANALYSIS OF VORICONAZOLE IN LUNG TRANSPLANT PATIENTS.
    Han, K.
    Bies, R.
    Capitano, B.
    Potoski, B.
    Gilbert, S.
    Paterson, D.
    McCurry, K.
    Venkataramanan, R.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S4 - S4
12345